RECRUITING

Dynamic Connectivity Under Metabolic Constraints

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

In this study, we investigate the impact of insulin resistance on the acceleration of brain aging, and test whether increased neuron insulin resistance can be counteracted by utilization of alternate metabolic pathways (e.g., ketones rather than glucose). This study has three Arms, which together provide synergistic data. For all three Arms, subjects are tested in a within-subjects design that consists of 2-3 testing sessions, 1-14 days apart, and counter-balanced for order. During each session we measure the impact of fuel (glucose in one session, ketones in the other) on brain metabolism and associated functioning. For Arms 1-2, our primary experimental measure is functional magnetic resonance imaging (fMRI), which we will use to trace the self-organization of functional networks following changes in energy supply and demand. Arm 1 tests the impact of endogenous ketones produced by switching to a low carbohydrate diet, while Arm 2 tests the impact of exogenous ketones consumed as a nutritional supplement. For Arm 3, we use simultaneous magnetic resonance spectroscopy/positron-emission tomography (MR/PET) to quantify the impact of exogenous ketones on production of glutamate and GABA, key neurotransmitters. Subjects will be given the option to participate in more than one of the Arms, but doing so is not expected nor required. Prior to scans, subjects will receive a clinician-administered History and Physical (H\&P), which includes vital signs, an oral glucose tolerance test (OGTT), and the comprehensive metabolic blood panel. These will be used to assess diabetes, kidney disease, and electrolytes. If subjects pass screening, they will be provided the option to participate in one or more Arms, which include neuroimaging. To provide a quantitative measure of time-varying metabolic activity throughout the scan, based upon quantitative models of glucose and ketone regulation, as well as to be able to implement safety stopping rules (see below), we will obtain pin-prick blood samples three times: prior to the scan, following consumption of the glucose or ketone drink, and following completion of the scan. To assess effects of increased metabolic demand, we measure brain response to cognitive load, transitioning from resting-state to spatial reasoning through a Tetris task. To assess effects of increased metabolic supply, we measure brain response to glucose or ketone bolus.

Official Title

Dynamic Connectivity Under Metabolic Constraints

Quick Facts

Study Start:2015-06-19
Study Completion:2023-09
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04840095

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 79 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * BMI \< 30
  2. * 20/20 vision or correctable to 20/20 with contact lenses
  3. * MRI compatible
  4. * For PET with Optional 150 ml Blood Sampling Only: Must weigh at least 110 lbs to minimize risks per PHRC guidelines.
  1. * claustrophobia
  2. * history of neurological disease, heart attack, stroke, kidney disease, or myxedema
  3. * chronic usage of alcohol
  4. * current usage of psychotropic medication
  5. * Type 1 diabetes mellitus
  6. * Regular consumption of insulin, Metformin® or other medications (statins, NSAIDs, beta-blockers, glucocorticoids) that affect glucose and/or insulin utilization.
  7. * difficulty swallowing
  8. * pregnancy
  9. * breastfeeding
  10. * For PET: research imaging-related radiation exposure that exceeds current MGH Radiology Radiation Safety Commitee guidelines.

Contacts and Locations

Study Contact

Lilianne Mujica-Parodi, PhD
CONTACT
631-371-4413
lilianne.strey@stonybrook.edu
Antoine Hone-Blanchet, PhD
CONTACT
ahone-blanchet@mgh.harvard.edu

Principal Investigator

Lilianne Mujica-Parodi, PhD
PRINCIPAL_INVESTIGATOR
Stony Brook University

Study Locations (Sites)

Martinos Center for Biomedical Research, Building 149
Charlestown, Massachusetts, 02129
United States
Bioengineering Building , Stony Brook University
Stony Brook, New York, 11794
United States

Collaborators and Investigators

Sponsor: Massachusetts General Hospital

  • Lilianne Mujica-Parodi, PhD, PRINCIPAL_INVESTIGATOR, Stony Brook University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2015-06-19
Study Completion Date2023-09

Study Record Updates

Study Start Date2015-06-19
Study Completion Date2023-09

Terms related to this study

Keywords Provided by Researchers

  • exogenous ketone
  • insulin resistance
  • glucose
  • diet
  • aging

Additional Relevant MeSH Terms

  • Insulin Resistance
  • Healthy
  • Diet Modification
  • Aging